CA
NZ
UK
AU
IND
US
Silence Therapeutics Plc (NASDAQ:SLN), whose American depositary shares trade in US dollars, has been in focus after reporting positive topline Phase 2 results for divesiran in polycythemia vera and raising capital. It has a market capitalisation near $573 million.
Syra Health Corp. (OTC:SYRA) has reported two consecutive profitable quarters, a milestone for a micro-cap healthcare services company. Second-quarter 2026 revenue rose 23% to $2.39 million with net income of $250,242, following a first quarter with net income of $240,979. More recently, the company …
Tectonic Therapeutic, Inc. (NASDAQ:TECX) is a clinical-stage biotech whose next major data event, a Phase 2 trial in pulmonary hypertension, is approaching. It has a market capitalisation near $441 million. A reported UBS initiation at Neutral with a $26 price target arrived over the …
OmniAb, Inc. (NASDAQ:OABI) has a market capitalisation of about $696 million and is drawing attention as investors weigh the company's October 6 Investor and Analyst Day. The focus is on company-specific developments: a raised cash forecast, a new collaboration with Eli Lilly and an …
Oculis Holding AG (NASDAQ:OCS) enters the new trading week with a changed investment narrative. Earlier this year the Switzerland-based ophthalmology developer reported that its two DIAMOND Phase 3 trials of OCS-01 eye drops in diabetic macular edema (DME) did not meet their primary endpoint, …
Progyny, Inc. (NASDAQ:PGNY), the fertility and family-building benefits manager, has a market capitalisation of about $2.14 billion. On October 7 the company said its selling season is pacing to a record level and that it expects 1.2 million new covered lives from commitments and …
P3 Health Partners (NASDAQ:PIII) enters the week with a very different earnings profile from a year ago. In its second-quarter 2026 results, released on August 10, the physician-enablement and value-based care operator reported net income of $15.7 million, compared with a net loss of …
Polaryx Therapeutics, Inc. (NASDAQ:PLYX), a clinical-stage biotech focused on rare paediatric lysosomal storage disorders, has a market capitalisation of about $99.7 million on 49.85 million shares. The company has said it expects to start its SOTERIA Phase 2 basket trial in the second half …
Healthcare Services Group, Inc. (NASDAQ:HCSG), a provider of housekeeping, laundry and dining services to healthcare facilities, has a market value of roughly $1.42 billion. With the company due to report third-quarter results on October 21 and a freshly announced acquisition in the news, the …
ICON plc (NASDAQ:ICLR), the Dublin-based contract research organisation, reported second-quarter 2026 results that combined soft profitability with strong demand indicators. Adjusted diluted EPS fell to $2.56 from $3.52 a year earlier, yet gross bookings grew 24.1% and the backlog reached $23.4 billion. The focus …
Please wait processing your request...